Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSU6162 in Bipolar Depression
NCT05296356Phase 2Recruiting
- Sponsor
- University of Gothenburg
- Start
- Oct 2021
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OSU-6162 in bipolar disorder (BD), sponsored by University of Gothenburg. Started Oct 2021; status: recruiting.
02
Drugs
OSU-6162
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05296356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05296356.